Lunai Bioworks (LNAI) vs Xenetic Biosciences (XBIO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Xenetic Biosciences is the larger company by market cap ($5.2 million vs $4.9 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | LNAI | XBIO |
|---|---|---|
| Share price | $1.09 | $2.21 |
| Market cap | $4.94M | $5.18M |
| 1-day change | -3.54% | +2.55% |
| EPS (TTM) | $-61.36 | $-1.15 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $13.28 | $10.24 |
| 52-week low | $1.08 | $1.87 |
| Distance from 52-week high | -91.79% | -78.42% |
| Average volume | 181.37K | 87.71K |
| Shares outstanding | 4.53M | 2.34M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
LNAI vs XBIO FAQ
Which is bigger, Lunai Bioworks or Xenetic Biosciences?
Xenetic Biosciences (XBIO) is larger, with a market capitalization of $5.18M compared with $4.94M for Lunai Bioworks (LNAI).
Are Lunai Bioworks and Xenetic Biosciences in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.